DexCom (DXCM)
(Delayed Data from NSDQ)
$69.46 USD
+0.52 (0.75%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $69.46 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth B Momentum C VGM
Balance Sheet
Fiscal Year End for DexCom, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 2,724 | 2,456 | 2,731 | 2,708 | 1,533 |
Receivables | 974 | 713 | 514 | 429 | 286 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 560 | 307 | 357 | 235 | 120 |
Other Current Assets | 168 | 193 | 82 | 54 | 30 |
Total Current Assets | 4,426 | 3,669 | 3,684 | 3,425 | 1,969 |
Net Property & Equipment | 1,113 | 1,056 | 802 | 515 | 321 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 419 | 341 | 221 | 216 | 0 |
Intangibles | 160 | 199 | 69 | 19 | 19 |
Deposits & Other Assets | 75 | 47 | 0 | 21 | 14 |
Total Assets | 6,265 | 5,392 | 4,864 | 4,291 | 2,395 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 773 | 0 | 0 | 0 |
Accounts Payable | 1,346 | 902 | 573 | 481 | 256 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 171 | 134 | 125 | 114 | 89 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 18 | 10 | 2 | 2 | 2 |
Total Current Liabilities | 1,556 | 1,839 | 721 | 614 | 360 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,434 | 1,198 | 1,703 | 1,667 | 1,060 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 126 | 128 | 90 | 81 | 20 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 4,196 | 3,260 | 2,612 | 2,464 | 1,512 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 3,515 | 2,258 | 2,505 | 2,125 | 1,676 |
Retained Earnings | 1,021 | 480 | -47 | -202 | -696 |
Other Equity | -17 | -12 | 1 | 3 | 2 |
Treasury Stock | 2,451 | 595 | 206 | 100 | 100 |
Total Shareholder's Equity | 2,069 | 2,132 | 2,252 | 1,827 | 883 |
Total Liabilities & Shareholder's Equity | 6,265 | 5,392 | 4,864 | 4,291 | 2,395 |
Total Common Equity | 2,069 | 2,132 | 2,252 | 1,827 | 883 |
Shares Outstanding | 386.30 | 386.20 | 387.60 | 384.10 | 366.10 |
Book Value Per Share | 5.35 | 5.52 | 5.81 | 4.76 | 2.41 |
Fiscal Year End for DexCom, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 3,121 | 2,897 | 2,724 | 3,240 | 3,636 |
Receivables | 945 | 979 | 974 | 786 | 751 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 570 | 589 | 560 | 499 | 421 |
Other Current Assets | 212 | 156 | 168 | 174 | 195 |
Total Current Assets | 4,848 | 4,621 | 4,426 | 4,698 | 5,003 |
Net Property & Equipment | 1,183 | 1,109 | 1,113 | 1,079 | 1,078 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 476 | 461 | 419 | 501 | 417 |
Intangibles | 138 | 147 | 160 | 170 | 180 |
Deposits & Other Assets | 83 | 78 | 75 | 74 | 67 |
Total Assets | 6,799 | 6,482 | 6,265 | 6,596 | 6,821 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 124 | 774 |
Accounts Payable | 1,570 | 1,447 | 1,346 | 1,373 | 1,157 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 116 | 111 | 171 | 151 | 109 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 15 | 16 | 18 | 9 | 9 |
Total Current Liabilities | 1,722 | 1,594 | 1,556 | 1,679 | 2,070 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,438 | 2,436 | 2,434 | 2,432 | 2,431 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 128 | 126 | 134 | 133 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 4,365 | 4,235 | 4,196 | 4,328 | 4,720 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,992 | 2,511 | 3,515 | 3,618 | 2,269 |
Retained Earnings | 1,311 | 1,168 | 1,021 | 765 | 644 |
Other Equity | -38 | -37 | -17 | -36 | -29 |
Treasury Stock | 832 | 1,395 | 2,451 | 2,080 | 784 |
Total Shareholder's Equity | 2,434 | 2,247 | 2,069 | 2,268 | 2,100 |
Total Liabilities & Shareholder's Equity | 6,799 | 6,482 | 6,265 | 6,596 | 6,821 |
Total Common Equity | 2,434 | 2,247 | 2,069 | 2,268 | 2,100 |
Shares Outstanding | 400.70 | 397.60 | 386.30 | 386.30 | 387.80 |
Book Value Per Share | 6.08 | 5.65 | 5.35 | 5.87 | 5.42 |